These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7949545

  • 21. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.
    Campistol JM, Eris J, Oberbauer R, Friend P, Hutchison B, Morales JM, Claesson K, Stallone G, Russ G, Rostaing L, Kreis H, Burke JT, Brault Y, Scarola JA, Neylan JF.
    J Am Soc Nephrol; 2006 Feb; 17(2):581-9. PubMed ID: 16434506
    [Abstract] [Full Text] [Related]

  • 22. Non-lymphoid cancer after liver transplantation.
    Frezza EE, Fung JJ, van Thiel DH.
    Hepatogastroenterology; 1997 Feb; 44(16):1172-81. PubMed ID: 9261620
    [Abstract] [Full Text] [Related]

  • 23. Retrospective study of the effects of cyclosporine in comparison with azathioprine on renal transplant recipients infected with hepatitis C virus.
    Ichikawa Y, Kishikawa H, Nishimura K, Tokugawa S, Yoshioka I, Arichi N, Fujii N, Kyo M, Nishikawa M.
    Transplant Proc; 2006 Dec; 38(10):3451-3. PubMed ID: 17175300
    [Abstract] [Full Text] [Related]

  • 24. The effect of immunosuppressive drugs on quality of life after renal transplantation.
    Hilbrands LB, Hoitsma AJ, Koene RA.
    Transplantation; 1995 May 15; 59(9):1263-70. PubMed ID: 7762059
    [Abstract] [Full Text] [Related]

  • 25. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 15; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 26. Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients.
    Hiesse C, Kriaa F, Rieu P, Larue JR, Benoit G, Bellamy J, Blanchet P, Charpentier B.
    Transplant Proc; 1995 Feb 15; 27(1):972-4. PubMed ID: 7879250
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 32. Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients.
    Langer RM, Kahan BD.
    Transplantation; 2003 Jul 27; 76(2):318-23. PubMed ID: 12883185
    [Abstract] [Full Text] [Related]

  • 33. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G, Döhler B, Collaborative Transplant Study.
    Transplantation; 2009 Mar 27; 87(6):795-802. PubMed ID: 19300179
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
    Kliem V, Fritsche L, Haller H, Suwelack B, Abendroth D, Fornara P, Pietruck F, Frei U, Donauer J, Lison AE, Michel U, Ulbricht B, International MOST Study Group.
    Transplant Proc; 2005 Apr 27; 37(3):1597-600. PubMed ID: 15866683
    [Abstract] [Full Text] [Related]

  • 36. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M, Iacob G, Lucan C, Lăpuşan C, Munteanu A, Sîrbu S.
    Transplant Proc; 2004 Mar 27; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [Abstract] [Full Text] [Related]

  • 37. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec 27; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 38. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment.
    Montagnino G, Lorca E, Tarantino A, Bencini P, Aroldi A, Cesana B, Braga M, Lonati F, Ponticelli C.
    Clin Transplant; 1996 Oct 27; 10(5):461-9. PubMed ID: 8930463
    [Abstract] [Full Text] [Related]

  • 39. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J, Ringdén O.
    Clin Transplant; 1994 Jun 27; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [Abstract] [Full Text] [Related]

  • 40. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
    Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J.
    Transplantation; 1989 Feb 27; 47(2):278-81. PubMed ID: 2645712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.